BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1100728 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1COC1 InChI=1S/C23H19Cl2F3N8O3/c24-15-5-3-13(4-6-15)19-33-35(9-18-30-12-36(32-18)20-16(25)2-1-7-29-20)22(38)34(19)8-17(23(26,27)28)31-21(37)14-10-39-11-14/h1-7,12,14,17H,8-11H2,(H,31,37) AVCHIPMGQBIBGJ-UHFFFAOYSA-N 521107 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}oxetane-3-carboxamide (Racemate)::US11149023, Example 1 Vasopressin V1a receptor Human 4.90 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521107 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521107&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564217 461598526 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100729 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1COC1 InChI=1S/C23H19Cl2F3N8O3/c24-15-5-3-13(4-6-15)19-33-35(9-18-30-12-36(32-18)20-16(25)2-1-7-29-20)22(38)34(19)8-17(23(26,27)28)31-21(37)14-10-39-11-14/h1-7,12,14,17H,8-11H2,(H,31,37) AVCHIPMGQBIBGJ-UHFFFAOYSA-N 521107 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}oxetane-3-carboxamide (Racemate)::US11149023, Example 1 Vasopressin V2 receptor Human 245 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521107 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521107&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564217 461598526 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100730 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CNC(=O)N1 InChI=1S/C23H19Cl2F3N10O3/c24-13-5-3-12(4-6-13)18-35-37(10-17-31-11-38(34-17)19-14(25)2-1-7-29-19)22(41)36(18)9-16(23(26,27)28)33-20(39)15-8-30-21(40)32-15/h1-7,11,15-16H,8-10H2,(H,33,39)(H2,30,32,40) DJAIDZGEVUVDAJ-UHFFFAOYSA-N 521108 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-trifluoropropan-2-yl}-1,1,1-trifluoropropan-2-yl}-2-oxoimidazolidine-4-carboxamide (Diastereomeric Mixture)::US11149023, Example 2 Vasopressin V1a receptor Human 40.5 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521108 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521108&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564224 461598527 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100731 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CNC(=O)N1 InChI=1S/C23H19Cl2F3N10O3/c24-13-5-3-12(4-6-13)18-35-37(10-17-31-11-38(34-17)19-14(25)2-1-7-29-19)22(41)36(18)9-16(23(26,27)28)33-20(39)15-8-30-21(40)32-15/h1-7,11,15-16H,8-10H2,(H,33,39)(H2,30,32,40) DJAIDZGEVUVDAJ-UHFFFAOYSA-N 521108 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-trifluoropropan-2-yl}-1,1,1-trifluoropropan-2-yl}-2-oxoimidazolidine-4-carboxamide (Diastereomeric Mixture)::US11149023, Example 2 Vasopressin V2 receptor Human 2400 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521108 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521108&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564224 461598527 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100732 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CCO1 InChI=1S/C23H19Cl2F3N8O3/c24-14-5-3-13(4-6-14)19-33-35(11-18-30-12-36(32-18)20-15(25)2-1-8-29-20)22(38)34(19)10-17(23(26,27)28)31-21(37)16-7-9-39-16/h1-6,8,12,16-17H,7,9-11H2,(H,31,37) SMYARTHGIPYMLP-UHFFFAOYSA-N 521109 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}oxetane-2-carboxamide (Diastereomeric Mixture)::US11149023, Example 3 Vasopressin V1a receptor Human 4.10 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521109&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564244 461598528 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100733 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CCO1 InChI=1S/C23H19Cl2F3N8O3/c24-14-5-3-13(4-6-14)19-33-35(11-18-30-12-36(32-18)20-15(25)2-1-8-29-20)22(38)34(19)10-17(23(26,27)28)31-21(37)16-7-9-39-16/h1-6,8,12,16-17H,7,9-11H2,(H,31,37) SMYARTHGIPYMLP-UHFFFAOYSA-N 521109 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}oxetane-2-carboxamide (Diastereomeric Mixture)::US11149023, Example 3 Vasopressin V2 receptor Human 445 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521109&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564244 461598528 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100734 CC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C21H17Cl2F3N8O2/c1-12(35)29-16(21(24,25)26)9-32-18(13-4-6-14(22)7-5-13)31-33(20(32)36)10-17-28-11-34(30-17)19-15(23)3-2-8-27-19/h2-8,11,16H,9-10H2,1H3,(H,29,35) MONAEVGELUOLRJ-UHFFFAOYSA-N 521110 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}acetamide (Racemate)::US11149023, Example 4 Vasopressin V1a receptor Human 55.5 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521110&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564229 461598529 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100735 CC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C21H17Cl2F3N8O2/c1-12(35)29-16(21(24,25)26)9-32-18(13-4-6-14(22)7-5-13)31-33(20(32)36)10-17-28-11-34(30-17)19-15(23)3-2-8-27-19/h2-8,11,16H,9-10H2,1H3,(H,29,35) MONAEVGELUOLRJ-UHFFFAOYSA-N 521110 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}acetamide (Racemate)::US11149023, Example 4 Vasopressin V2 receptor Human 1850 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521110&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564229 461598529 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100736 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)CC#N InChI=1S/C22H16Cl2F3N9O2/c23-14-5-3-13(4-6-14)19-33-35(11-17-30-12-36(32-17)20-15(24)2-1-9-29-20)21(38)34(19)10-16(22(25,26)27)31-18(37)7-8-28/h1-6,9,12,16H,7,10-11H2,(H,31,37) WRSXZHXSQUDMHG-UHFFFAOYSA-N 521111 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-cyanoacetamide (Racemate)::US11149023, Example 5 Vasopressin V1a receptor Human 10.6 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521111&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 152312727 461598530 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100737 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)CC#N InChI=1S/C22H16Cl2F3N9O2/c23-14-5-3-13(4-6-14)19-33-35(11-17-30-12-36(32-17)20-15(24)2-1-9-29-20)21(38)34(19)10-16(22(25,26)27)31-18(37)7-8-28/h1-6,9,12,16H,7,10-11H2,(H,31,37) WRSXZHXSQUDMHG-UHFFFAOYSA-N 521111 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-cyanoacetamide (Racemate)::US11149023, Example 5 Vasopressin V2 receptor Human 595 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521111&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 152312727 461598530 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100738 COCC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H19Cl2F3N8O3/c1-38-11-18(36)30-16(22(25,26)27)9-33-19(13-4-6-14(23)7-5-13)32-34(21(33)37)10-17-29-12-35(31-17)20-15(24)3-2-8-28-20/h2-8,12,16H,9-11H2,1H3,(H,30,36) DVODPQDNNINMKU-UHFFFAOYSA-N 521112 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-methoxyacetamide (Racemate)::US11149023, Example 6 Vasopressin V1a receptor Human 5.65 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521112&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564243 461598531 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100739 COCC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H19Cl2F3N8O3/c1-38-11-18(36)30-16(22(25,26)27)9-33-19(13-4-6-14(23)7-5-13)32-34(21(33)37)10-17-29-12-35(31-17)20-15(24)3-2-8-28-20/h2-8,12,16H,9-11H2,1H3,(H,30,36) DVODPQDNNINMKU-UHFFFAOYSA-N 521112 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-methoxyacetamide (Racemate)::US11149023, Example 6 Vasopressin V2 receptor Human 630 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521112&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564243 461598531 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100740 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CC1(F)F InChI=1S/C23H17Cl2F5N8O2/c24-13-5-3-12(4-6-13)18-35-37(10-17-32-11-38(34-17)19-15(25)2-1-7-31-19)21(40)36(18)9-16(23(28,29)30)33-20(39)14-8-22(14,26)27/h1-7,11,14,16H,8-10H2,(H,33,39) RPDVXKRTSHQHKP-UHFFFAOYSA-N 521113 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2,2-difluorocyclopropanecarboxamide (Diastereomeric Mixture)::US11149023, Example 7 Vasopressin V1a receptor Human 1.65 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521113&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564210 461598532 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100741 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CC1(F)F InChI=1S/C23H17Cl2F5N8O2/c24-13-5-3-12(4-6-13)18-35-37(10-17-32-11-38(34-17)19-15(25)2-1-7-31-19)21(40)36(18)9-16(23(28,29)30)33-20(39)14-8-22(14,26)27/h1-7,11,14,16H,8-10H2,(H,33,39) RPDVXKRTSHQHKP-UHFFFAOYSA-N 521113 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2,2-difluorocyclopropanecarboxamide (Diastereomeric Mixture)::US11149023, Example 7 Vasopressin V2 receptor Human 130 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521113&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564210 461598532 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100742 FCC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C21H16Cl2F4N8O2/c22-13-5-3-12(4-6-13)18-32-34(10-16-29-11-35(31-16)19-14(23)2-1-7-28-19)20(37)33(18)9-15(21(25,26)27)30-17(36)8-24/h1-7,11,15H,8-10H2,(H,30,36) TXYVTFJAFVUKAQ-UHFFFAOYSA-N 521114 N-{(3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-fluoroacetamide (Racemate)::US11149023, Example 8 Vasopressin V1a receptor Human 42.5 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521114&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564256 461598533 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100743 FCC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C21H16Cl2F4N8O2/c22-13-5-3-12(4-6-13)18-32-34(10-16-29-11-35(31-16)19-14(23)2-1-7-28-19)20(37)33(18)9-15(21(25,26)27)30-17(36)8-24/h1-7,11,15H,8-10H2,(H,30,36) TXYVTFJAFVUKAQ-UHFFFAOYSA-N 521114 N-{(3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-fluoroacetamide (Racemate)::US11149023, Example 8 Vasopressin V2 receptor Human 2200 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521114&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564256 461598533 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100744 CC(F)(F)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H17Cl2F5N8O2/c1-21(25,26)19(38)32-15(22(27,28)29)9-35-17(12-4-6-13(23)7-5-12)34-36(20(35)39)10-16-31-11-37(33-16)18-14(24)3-2-8-30-18/h2-8,11,15H,9-10H2,1H3,(H,32,38) NDSPEUMHGNVTHS-UHFFFAOYSA-N 521115 N-{(3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2,2-difluoropropanamide (Racemate)::US11149023, Example 9 Vasopressin V1a receptor Human 10.00 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521115 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521115&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621884 461598534 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100745 CC(F)(F)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H17Cl2F5N8O2/c1-21(25,26)19(38)32-15(22(27,28)29)9-35-17(12-4-6-13(23)7-5-12)34-36(20(35)39)10-16-31-11-37(33-16)18-14(24)3-2-8-30-18/h2-8,11,15H,9-10H2,1H3,(H,32,38) NDSPEUMHGNVTHS-UHFFFAOYSA-N 521115 N-{(3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2,2-difluoropropanamide (Racemate)::US11149023, Example 9 Vasopressin V2 receptor Human 660 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521115 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521115&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621884 461598534 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100746 CC(F)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H18Cl2F4N8O2/c1-12(25)20(37)31-16(22(26,27)28)9-34-18(13-4-6-14(23)7-5-13)33-35(21(34)38)10-17-30-11-36(32-17)19-15(24)3-2-8-29-19/h2-8,11-12,16H,9-10H2,1H3,(H,31,37) MMJYONSQOWKBFO-UHFFFAOYSA-N 521116 N-{(3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-fluoropropanamide (Diastereomeric Mixture)::US11149023, Example 10 Vasopressin V1a receptor Human 6.10 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521116 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521116&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564225 461598535 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100747 CC(F)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H18Cl2F4N8O2/c1-12(25)20(37)31-16(22(26,27)28)9-34-18(13-4-6-14(23)7-5-13)33-35(21(34)38)10-17-30-11-36(32-17)19-15(24)3-2-8-29-19/h2-8,11-12,16H,9-10H2,1H3,(H,31,37) MMJYONSQOWKBFO-UHFFFAOYSA-N 521116 N-{(3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-fluoropropanamide (Diastereomeric Mixture)::US11149023, Example 10 Vasopressin V2 receptor Human 365 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521116 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521116&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564225 461598535 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100748 FC(F)(F)CC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H16Cl2F6N8O2/c23-13-5-3-12(4-6-13)18-35-37(10-16-32-11-38(34-16)19-14(24)2-1-7-31-19)20(40)36(18)9-15(22(28,29)30)33-17(39)8-21(25,26)27/h1-7,11,15H,8-10H2,(H,33,39) HKNSUPCHOJIVAF-UHFFFAOYSA-N 521117 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-3,3,3-trifluoropropanamide (Racemate)::US11149023, Example 11 Vasopressin V1a receptor Human 1.20 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521117&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564240 461598536 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100749 FC(F)(F)CC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H16Cl2F6N8O2/c23-13-5-3-12(4-6-13)18-35-37(10-16-32-11-38(34-16)19-14(24)2-1-7-31-19)20(40)36(18)9-15(22(28,29)30)33-17(39)8-21(25,26)27/h1-7,11,15H,8-10H2,(H,33,39) HKNSUPCHOJIVAF-UHFFFAOYSA-N 521117 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-3,3,3-trifluoropropanamide (Racemate)::US11149023, Example 11 Vasopressin V2 receptor Human 45.5 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521117&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564240 461598536 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100750 FC1CC1C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H18Cl2F4N8O2/c24-13-5-3-12(4-6-13)19-34-36(10-18-31-11-37(33-18)20-15(25)2-1-7-30-20)22(39)35(19)9-17(23(27,28)29)32-21(38)14-8-16(14)26/h1-7,11,14,16-17H,8-10H2,(H,32,38) MGZYKGFINIZGRY-UHFFFAOYSA-N 521118 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-fluorocyclopropanecarboxamide (Diastereomeric Mixture)::US11149023, Example 12 Vasopressin V1a receptor Human 22.5 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521118&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564228 461598537 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100751 FC1CC1C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H18Cl2F4N8O2/c24-13-5-3-12(4-6-13)19-34-36(10-18-31-11-37(33-18)20-15(25)2-1-7-30-20)22(39)35(19)9-17(23(27,28)29)32-21(38)14-8-16(14)26/h1-7,11,14,16-17H,8-10H2,(H,32,38) MGZYKGFINIZGRY-UHFFFAOYSA-N 521118 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-fluorocyclopropanecarboxamide (Diastereomeric Mixture)::US11149023, Example 12 Vasopressin V2 receptor Human 560 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521118&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564228 461598537 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100752 CCC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H19Cl2F3N8O2/c1-2-18(36)30-16(22(25,26)27)10-33-19(13-5-7-14(23)8-6-13)32-34(21(33)37)11-17-29-12-35(31-17)20-15(24)4-3-9-28-20/h3-9,12,16H,2,10-11H2,1H3,(H,30,36) IYTPQPZUIVPAJS-UHFFFAOYSA-N 521119 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}propanamide (Racemate)::US11149023, Example 13 Vasopressin V1a receptor Human 6.95 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521119&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564267 461598538 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100753 CCC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H19Cl2F3N8O2/c1-2-18(36)30-16(22(25,26)27)10-33-19(13-5-7-14(23)8-6-13)32-34(21(33)37)11-17-29-12-35(31-17)20-15(24)4-3-9-28-20/h3-9,12,16H,2,10-11H2,1H3,(H,30,36) IYTPQPZUIVPAJS-UHFFFAOYSA-N 521119 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}propanamide (Racemate)::US11149023, Example 13 Vasopressin V2 receptor Human 260 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521119&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564267 461598538 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100754 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CC1 InChI=1S/C23H19Cl2F3N8O2/c24-15-7-5-13(6-8-15)19-33-35(11-18-30-12-36(32-18)20-16(25)2-1-9-29-20)22(38)34(19)10-17(23(26,27)28)31-21(37)14-3-4-14/h1-2,5-9,12,14,17H,3-4,10-11H2,(H,31,37) FVLCKBLZUIFTMR-UHFFFAOYSA-N 521120 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}cyclopropanecarboxamide (Racemate)::US11149023, Example 14 Vasopressin V1a receptor Human 12.4 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521120 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521120&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564209 461598539 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100755 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CC1 InChI=1S/C23H19Cl2F3N8O2/c24-15-7-5-13(6-8-15)19-33-35(11-18-30-12-36(32-18)20-16(25)2-1-9-29-20)22(38)34(19)10-17(23(26,27)28)31-21(37)14-3-4-14/h1-2,5-9,12,14,17H,3-4,10-11H2,(H,31,37) FVLCKBLZUIFTMR-UHFFFAOYSA-N 521120 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}cyclopropanecarboxamide (Racemate)::US11149023, Example 14 Vasopressin V2 receptor Human 220 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521120 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521120&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564209 461598539 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100756 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CC(F)(F)C1 InChI=1S/C24H19Cl2F5N8O2/c25-15-5-3-13(4-6-15)19-36-38(11-18-33-12-39(35-18)20-16(26)2-1-7-32-20)22(41)37(19)10-17(24(29,30)31)34-21(40)14-8-23(27,28)9-14/h1-7,12,14,17H,8-11H2,(H,34,40) KPDNAZVBCCYSTG-UHFFFAOYSA-N 521121 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-3,3-difluorocyclobutanecarboxamide (Racemate)::US11149023, Example 15 Vasopressin V1a receptor Human 2.05 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521121&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564227 461598540 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100757 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CC(F)(F)C1 InChI=1S/C24H19Cl2F5N8O2/c25-15-5-3-13(4-6-15)19-36-38(11-18-33-12-39(35-18)20-16(26)2-1-7-32-20)22(41)37(19)10-17(24(29,30)31)34-21(40)14-8-23(27,28)9-14/h1-7,12,14,17H,8-11H2,(H,34,40) KPDNAZVBCCYSTG-UHFFFAOYSA-N 521121 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-3,3-difluorocyclobutanecarboxamide (Racemate)::US11149023, Example 15 Vasopressin V2 receptor Human 78.5 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521121&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564227 461598540 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100758 CC(=O)OC(C)(C)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C25H23Cl2F3N8O4/c1-14(39)42-24(2,3)22(40)33-18(25(28,29)30)11-36-20(15-6-8-16(26)9-7-15)35-37(23(36)41)12-19-32-13-38(34-19)21-17(27)5-4-10-31-21/h4-10,13,18H,11-12H2,1-3H3,(H,33,40) KZYINFBORHZVKJ-UHFFFAOYSA-N 521122 1-({3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}amino)-2-methyl-1-oxopropan-2-yl acetate (Racemate)::US11149023, Example 16 Vasopressin V1a receptor Human 5.05 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521122&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564252 461598541 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100759 CC(=O)OC(C)(C)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C25H23Cl2F3N8O4/c1-14(39)42-24(2,3)22(40)33-18(25(28,29)30)11-36-20(15-6-8-16(26)9-7-15)35-37(23(36)41)12-19-32-13-38(34-19)21-17(27)5-4-10-31-21/h4-10,13,18H,11-12H2,1-3H3,(H,33,40) KZYINFBORHZVKJ-UHFFFAOYSA-N 521122 1-({3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}amino)-2-methyl-1-oxopropan-2-yl acetate (Racemate)::US11149023, Example 16 Vasopressin V2 receptor Human 140 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521122&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564252 461598541 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100760 CC(C)(O)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H21Cl2F3N8O3/c1-22(2,39)20(37)31-16(23(26,27)28)10-34-18(13-5-7-14(24)8-6-13)33-35(21(34)38)11-17-30-12-36(32-17)19-15(25)4-3-9-29-19/h3-9,12,16,39H,10-11H2,1-2H3,(H,31,37) CRPDZUWQFXLWLT-UHFFFAOYSA-N 521123 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-hydroxy-2-methylpropanamide (Racemate)::US11149023, Example 17 Vasopressin V1a receptor Human 9.55 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521123&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564265 461598542 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100761 CC(C)(O)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H21Cl2F3N8O3/c1-22(2,39)20(37)31-16(23(26,27)28)10-34-18(13-5-7-14(24)8-6-13)33-35(21(34)38)11-17-30-12-36(32-17)19-15(25)4-3-9-29-19/h3-9,12,16,39H,10-11H2,1-2H3,(H,31,37) CRPDZUWQFXLWLT-UHFFFAOYSA-N 521123 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-hydroxy-2-methylpropanamide (Racemate)::US11149023, Example 17 Vasopressin V2 receptor Human 280 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521123&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564265 461598542 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100762 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CC1C(F)(F)F InChI=1S/C24H18Cl2F6N8O2/c25-13-5-3-12(4-6-13)19-37-39(10-18-34-11-40(36-18)20-16(26)2-1-7-33-20)22(42)38(19)9-17(24(30,31)32)35-21(41)14-8-15(14)23(27,28)29/h1-7,11,14-15,17H,8-10H2,(H,35,41) RUOURPLXVUWWKS-UHFFFAOYSA-N 521124 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-(trifluoromethyl)cyclopropanecarboxamide (Diastereomeric Mixture)::US11149023, Example 18 Vasopressin V1a receptor Human 2.50 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521124&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564212 461598543 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100763 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CC1C(F)(F)F InChI=1S/C24H18Cl2F6N8O2/c25-13-5-3-12(4-6-13)19-37-39(10-18-34-11-40(36-18)20-16(26)2-1-7-33-20)22(42)38(19)9-17(24(30,31)32)35-21(41)14-8-15(14)23(27,28)29/h1-7,11,14-15,17H,8-10H2,(H,35,41) RUOURPLXVUWWKS-UHFFFAOYSA-N 521124 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-(trifluoromethyl)cyclopropanecarboxamide (Diastereomeric Mixture)::US11149023, Example 18 Vasopressin V2 receptor Human 33.5 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521124&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564212 461598543 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100764 CS(=O)(=O)NCC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H20Cl2F3N9O4S/c1-41(39,40)30-9-18(37)31-16(22(25,26)27)10-34-19(13-4-6-14(23)7-5-13)33-35(21(34)38)11-17-29-12-36(32-17)20-15(24)3-2-8-28-20/h2-8,12,16,30H,9-11H2,1H3,(H,31,37) PCWMGEPBSLMVKO-UHFFFAOYSA-N 521125 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-N2-(methylsulfonyl)glycinamide (Racemate)::US11149023, Example 19 Vasopressin V1a receptor Human 2.20 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521125&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564203 461598544 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100765 CS(=O)(=O)NCC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H20Cl2F3N9O4S/c1-41(39,40)30-9-18(37)31-16(22(25,26)27)10-34-19(13-4-6-14(23)7-5-13)33-35(21(34)38)11-17-29-12-36(32-17)20-15(24)3-2-8-28-20/h2-8,12,16,30H,9-11H2,1H3,(H,31,37) PCWMGEPBSLMVKO-UHFFFAOYSA-N 521125 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-N2-(methylsulfonyl)glycinamide (Racemate)::US11149023, Example 19 Vasopressin V2 receptor Human 102 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521125&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564203 461598544 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100766 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)CN1CCOC1=O InChI=1S/C24H20Cl2F3N9O4/c25-15-5-3-14(4-6-15)20-34-37(11-18-31-13-38(33-18)21-16(26)2-1-7-30-21)22(40)36(20)10-17(24(27,28)29)32-19(39)12-35-8-9-42-23(35)41/h1-7,13,17H,8-12H2,(H,32,39) MDCQFDQSPQMOFE-UHFFFAOYSA-N 521126 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide (Racemate)::US11149023, Example 20 Vasopressin V1a receptor Human 8.90 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521126 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521126&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564215 461598545 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100767 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)CN1CCOC1=O InChI=1S/C24H20Cl2F3N9O4/c25-15-5-3-14(4-6-15)20-34-37(11-18-31-13-38(33-18)21-16(26)2-1-7-30-21)22(40)36(20)10-17(24(27,28)29)32-19(39)12-35-8-9-42-23(35)41/h1-7,13,17H,8-12H2,(H,32,39) MDCQFDQSPQMOFE-UHFFFAOYSA-N 521126 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide (Racemate)::US11149023, Example 20 Vasopressin V2 receptor Human 520 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521126 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521126&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564215 461598545 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100768 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1(CC1)C#N InChI=1S/C24H18Cl2F3N9O2/c25-15-5-3-14(4-6-15)19-35-37(11-18-32-13-38(34-18)20-16(26)2-1-9-31-20)22(40)36(19)10-17(24(27,28)29)33-21(39)23(12-30)7-8-23/h1-6,9,13,17H,7-8,10-11H2,(H,33,39) BNENBOYVNATGJM-UHFFFAOYSA-N 521127 N-{(3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-1-cyanocyclopropanecarboxamide (Racemate)::US11149023, Example 21 Vasopressin V1a receptor Human 5.95 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521127 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521127&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564233 461598546 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100769 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1(CC1)C#N InChI=1S/C24H18Cl2F3N9O2/c25-15-5-3-14(4-6-15)19-35-37(11-18-32-13-38(34-18)20-16(26)2-1-9-31-20)22(40)36(19)10-17(24(27,28)29)33-21(39)23(12-30)7-8-23/h1-6,9,13,17H,7-8,10-11H2,(H,33,39) BNENBOYVNATGJM-UHFFFAOYSA-N 521127 N-{(3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-1-cyanocyclopropanecarboxamide (Racemate)::US11149023, Example 21 Vasopressin V2 receptor Human 282 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521127 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521127&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564233 461598546 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100770 OC1(CC1)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H19Cl2F3N8O3/c24-14-5-3-13(4-6-14)18-33-35(11-17-30-12-36(32-17)19-15(25)2-1-9-29-19)21(38)34(18)10-16(23(26,27)28)31-20(37)22(39)7-8-22/h1-6,9,12,16,39H,7-8,10-11H2,(H,31,37) AEOQUILQVQWNLS-UHFFFAOYSA-N 521128 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-1-hydroxycyclopropanecarboxamide (Racemate)::US11149023, Example 22 Vasopressin V1a receptor Human 4.05 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521128&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564253 461598547 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100771 OC1(CC1)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H19Cl2F3N8O3/c24-14-5-3-13(4-6-14)18-33-35(11-17-30-12-36(32-17)19-15(25)2-1-9-29-19)21(38)34(18)10-16(23(26,27)28)31-20(37)22(39)7-8-22/h1-6,9,12,16,39H,7-8,10-11H2,(H,31,37) AEOQUILQVQWNLS-UHFFFAOYSA-N 521128 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-1-hydroxycyclopropanecarboxamide (Racemate)::US11149023, Example 22 Vasopressin V2 receptor Human 150 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521128&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564253 461598547 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100772 CC(C)(C)OC(=O)N1CCC(C1)C(=O)NC(CN(C(=O)NCc1ncn(n1)-c1ncccc1Cl)C(=N)c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C29H32Cl2F3N9O4/c1-28(2,3)47-27(46)41-12-10-18(14-41)25(44)39-21(29(32,33)34)15-42(23(35)17-6-8-19(30)9-7-17)26(45)37-13-22-38-16-43(40-22)24-20(31)5-4-11-36-24/h4-9,11,16,18,21,35H,10,12-15H2,1-3H3,(H,37,45)(H,39,44) WEFIJLZIAONNPW-UHFFFAOYSA-N 521129 US11149023, Example 23::tert-Butyl 3-({3-[3-(4-chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}carbamoyl)pyrrolidine-1-carboxylate (Diastereomeric Mixture) Vasopressin V1a receptor Human 1.01 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521129&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621917 461598548 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100773 CC(C)(C)OC(=O)N1CCC(C1)C(=O)NC(CN(C(=O)NCc1ncn(n1)-c1ncccc1Cl)C(=N)c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C29H32Cl2F3N9O4/c1-28(2,3)47-27(46)41-12-10-18(14-41)25(44)39-21(29(32,33)34)15-42(23(35)17-6-8-19(30)9-7-17)26(45)37-13-22-38-16-43(40-22)24-20(31)5-4-11-36-24/h4-9,11,16,18,21,35H,10,12-15H2,1-3H3,(H,37,45)(H,39,44) WEFIJLZIAONNPW-UHFFFAOYSA-N 521129 US11149023, Example 23::tert-Butyl 3-({3-[3-(4-chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}carbamoyl)pyrrolidine-1-carboxylate (Diastereomeric Mixture) Vasopressin V2 receptor Human 72.5 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521129&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621917 461598548 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100774 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CCNC1 InChI=1S/C24H22Cl2F3N9O2/c25-16-5-3-14(4-6-16)20-35-37(12-19-32-13-38(34-19)21-17(26)2-1-8-31-21)23(40)36(20)11-18(24(27,28)29)33-22(39)15-7-9-30-10-15/h1-6,8,13,15,18,30H,7,9-12H2,(H,33,39) MZAVMIIYQKZJCP-UHFFFAOYSA-N 521130 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}pyrrolidine-3-carboxamide (Diastereomeric Mixture)::US11149023, Example 24 Vasopressin V1a receptor Human 4.40 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521130&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621894 461598549 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100775 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CCNC1 InChI=1S/C24H22Cl2F3N9O2/c25-16-5-3-14(4-6-16)20-35-37(12-19-32-13-38(34-19)21-17(26)2-1-8-31-21)23(40)36(20)11-18(24(27,28)29)33-22(39)15-7-9-30-10-15/h1-6,8,13,15,18,30H,7,9-12H2,(H,33,39) MZAVMIIYQKZJCP-UHFFFAOYSA-N 521130 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}pyrrolidine-3-carboxamide (Diastereomeric Mixture)::US11149023, Example 24 Vasopressin V2 receptor Human 708 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521130&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621894 461598549 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100776 FC(F)(F)\C=C\C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H16Cl2F6N8O2/c24-14-5-3-13(4-6-14)19-36-38(11-17-33-12-39(35-17)20-15(25)2-1-9-32-20)21(41)37(19)10-16(23(29,30)31)34-18(40)7-8-22(26,27)28/h1-9,12,16H,10-11H2,(H,34,40)/b8-7+ ISUZSWPWZCNHEU-BQYQJAHWSA-N 521131 (2E)-N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-4,4,4-trifluorobut-2-enamide (Racemate)::US11149023, Example 25 Vasopressin V1a receptor Human 1.75 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521131 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521131&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621888 461598550 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100777 FC(F)(F)\C=C\C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H16Cl2F6N8O2/c24-14-5-3-13(4-6-14)19-36-38(11-17-33-12-39(35-17)20-15(25)2-1-9-32-20)21(41)37(19)10-16(23(29,30)31)34-18(40)7-8-22(26,27)28/h1-9,12,16H,10-11H2,(H,34,40)/b8-7+ ISUZSWPWZCNHEU-BQYQJAHWSA-N 521131 (2E)-N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-4,4,4-trifluorobut-2-enamide (Racemate)::US11149023, Example 25 Vasopressin V2 receptor Human 172 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521131 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521131&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621888 461598550 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100778 CC(C)(C)OC(=O)NC1(CC1)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C28H28Cl2F3N9O4/c1-26(2,3)46-24(44)37-27(10-11-27)23(43)36-19(28(31,32)33)13-40-21(16-6-8-17(29)9-7-16)39-41(25(40)45)14-20-35-15-42(38-20)22-18(30)5-4-12-34-22/h4-9,12,15,19H,10-11,13-14H2,1-3H3,(H,36,43)(H,37,44) JUNJJZGYUIARTF-UHFFFAOYSA-N 521132 US11149023, Example 26::tert-Butyl [1-({3-[3-(4-chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}carbamoyl)cyclopropyl]-carbamate (Racemate) Vasopressin V1a receptor Human 9.15 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521132&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564213 461598551 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100779 CC(C)(C)OC(=O)NC1(CC1)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C28H28Cl2F3N9O4/c1-26(2,3)46-24(44)37-27(10-11-27)23(43)36-19(28(31,32)33)13-40-21(16-6-8-17(29)9-7-16)39-41(25(40)45)14-20-35-15-42(38-20)22-18(30)5-4-12-34-22/h4-9,12,15,19H,10-11,13-14H2,1-3H3,(H,36,43)(H,37,44) JUNJJZGYUIARTF-UHFFFAOYSA-N 521132 US11149023, Example 26::tert-Butyl [1-({3-[3-(4-chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}carbamoyl)cyclopropyl]-carbamate (Racemate) Vasopressin V2 receptor Human 82.5 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521132&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564213 461598551 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100780 NC1(CC1)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H20Cl2F3N9O2/c24-14-5-3-13(4-6-14)18-34-36(11-17-31-12-37(33-17)19-15(25)2-1-9-30-19)21(39)35(18)10-16(23(26,27)28)32-20(38)22(29)7-8-22/h1-6,9,12,16H,7-8,10-11,29H2,(H,32,38) PSPCOLNRYHHQRX-UHFFFAOYSA-N 521133 1-Amino-N-{3-[3-(4-chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}cyclopropanecarboxamide (Racemate)::US11149023, Example 27 Vasopressin V1a receptor Human 215 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521133&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564204 461598552 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100781 NC1(CC1)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H20Cl2F3N9O2/c24-14-5-3-13(4-6-14)18-34-36(11-17-31-12-37(33-17)19-15(25)2-1-9-30-19)21(39)35(18)10-16(23(26,27)28)32-20(38)22(29)7-8-22/h1-6,9,12,16H,7-8,10-11,29H2,(H,32,38) PSPCOLNRYHHQRX-UHFFFAOYSA-N 521133 1-Amino-N-{3-[3-(4-chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}cyclopropanecarboxamide (Racemate)::US11149023, Example 27 Vasopressin V2 receptor Human 1900 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521133&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564204 461598552 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100782 CC(C)(C)OC(=O)NC1(CCC1)C(=O)NC(CN(C(=O)NCC1NN(C=N1)c1ncccc1Cl)C(=N)c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C29H34Cl2F3N9O4/c1-27(2,3)47-26(46)40-28(11-5-12-28)24(44)39-20(29(32,33)34)15-42(22(35)17-7-9-18(30)10-8-17)25(45)37-14-21-38-16-43(41-21)23-19(31)6-4-13-36-23/h4,6-10,13,16,20-21,35,41H,5,11-12,14-15H2,1-3H3,(H,37,45)(H,39,44)(H,40,46) BAJYTSHFKZLMBX-UHFFFAOYSA-N 521134 US11149023, Example 28::tert-Butyl [1-({3-[3-(4-chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}carbamoyl)cyclobutyl]-carbamate (Racemate) Vasopressin V1a receptor Human 1.85 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521134&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621909 461598553 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100783 CC(C)(C)OC(=O)NC1(CCC1)C(=O)NC(CN(C(=O)NCC1NN(C=N1)c1ncccc1Cl)C(=N)c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C29H34Cl2F3N9O4/c1-27(2,3)47-26(46)40-28(11-5-12-28)24(44)39-20(29(32,33)34)15-42(22(35)17-7-9-18(30)10-8-17)25(45)37-14-21-38-16-43(41-21)23-19(31)6-4-13-36-23/h4,6-10,13,16,20-21,35,41H,5,11-12,14-15H2,1-3H3,(H,37,45)(H,39,44)(H,40,46) BAJYTSHFKZLMBX-UHFFFAOYSA-N 521134 US11149023, Example 28::tert-Butyl [1-({3-[3-(4-chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}carbamoyl)cyclobutyl]-carbamate (Racemate) Vasopressin V2 receptor Human 22.5 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521134&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621909 461598553 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100784 NC1(CCC1)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C24H22Cl2F3N9O2/c25-15-6-4-14(5-7-15)19-35-37(12-18-32-13-38(34-18)20-16(26)3-1-10-31-20)22(40)36(19)11-17(24(27,28)29)33-21(39)23(30)8-2-9-23/h1,3-7,10,13,17H,2,8-9,11-12,30H2,(H,33,39) VDUORTCBRAITLJ-UHFFFAOYSA-N 521135 1-Amino-N-{3-[3-(4-chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}cyclobutanecarboxamide (Racemate)::US11149023, Example 29 Vasopressin V1a receptor Human 5.65 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521135&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564207 461598554 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100785 NC1(CCC1)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C24H22Cl2F3N9O2/c25-15-6-4-14(5-7-15)19-35-37(12-18-32-13-38(34-18)20-16(26)3-1-10-31-20)22(40)36(19)11-17(24(27,28)29)33-21(39)23(30)8-2-9-23/h1,3-7,10,13,17H,2,8-9,11-12,30H2,(H,33,39) VDUORTCBRAITLJ-UHFFFAOYSA-N 521135 1-Amino-N-{3-[3-(4-chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}cyclobutanecarboxamide (Racemate)::US11149023, Example 29 Vasopressin V2 receptor Human 203 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521135&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564207 461598554 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100786 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CCS(=O)(=O)C1 InChI=1S/C24H21Cl2F3N8O4S/c25-16-5-3-14(4-6-16)20-34-36(11-19-31-13-37(33-19)21-17(26)2-1-8-30-21)23(39)35(20)10-18(24(27,28)29)32-22(38)15-7-9-42(40,41)12-15/h1-6,8,13,15,18H,7,9-12H2,(H,32,38) LBPVMLAHLBOLKT-UHFFFAOYSA-N 521136 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}tetrahydrothiophene-3-carboxamide 1,1-dioxide (Diastereomeric Mixture)::US11149023, Example 30 Vasopressin V1a receptor Human 6.30 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521136&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621893 461598555 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100787 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CCS(=O)(=O)C1 InChI=1S/C24H21Cl2F3N8O4S/c25-16-5-3-14(4-6-16)20-34-36(11-19-31-13-37(33-19)21-17(26)2-1-8-30-21)23(39)35(20)10-18(24(27,28)29)32-22(38)15-7-9-42(40,41)12-15/h1-6,8,13,15,18H,7,9-12H2,(H,32,38) LBPVMLAHLBOLKT-UHFFFAOYSA-N 521136 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}tetrahydrothiophene-3-carboxamide 1,1-dioxide (Diastereomeric Mixture)::US11149023, Example 30 Vasopressin V2 receptor Human 213 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521136&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621893 461598555 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100788 FC(F)=C(F)CC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H16Cl2F6N8O2/c24-13-5-3-12(4-6-13)20-36-38(10-17-33-11-39(35-17)21-14(25)2-1-7-32-21)22(41)37(20)9-16(23(29,30)31)34-18(40)8-15(26)19(27)28/h1-7,11,16H,8-10H2,(H,34,40) POUFGALOZFJHJJ-UHFFFAOYSA-N 521137 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-3,4,4-trifluorobut-3-enamide (Racemate)::US11149023, Example 31 Vasopressin V1a receptor Human 3.40 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521137&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 155045866 461598556 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100789 FC(F)=C(F)CC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H16Cl2F6N8O2/c24-13-5-3-12(4-6-13)20-36-38(10-17-33-11-39(35-17)21-14(25)2-1-7-32-21)22(41)37(20)9-16(23(29,30)31)34-18(40)8-15(26)19(27)28/h1-7,11,16H,8-10H2,(H,34,40) POUFGALOZFJHJJ-UHFFFAOYSA-N 521137 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-3,4,4-trifluorobut-3-enamide (Racemate)::US11149023, Example 31 Vasopressin V2 receptor Human 109 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521137&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 155045866 461598556 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100790 FC(F)(F)CCC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H18Cl2F6N8O2/c24-14-5-3-13(4-6-14)19-36-38(11-17-33-12-39(35-17)20-15(25)2-1-9-32-20)21(41)37(19)10-16(23(29,30)31)34-18(40)7-8-22(26,27)28/h1-6,9,12,16H,7-8,10-11H2,(H,34,40) PECYYLGJQLWWIB-UHFFFAOYSA-N 521138 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-4,4,4-trifluorobutanamide (Racemate)::US11149023, Example 32 Vasopressin V1a receptor Human 1.17 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521138&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564231 461598557 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100791 FC(F)(F)CCC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H18Cl2F6N8O2/c24-14-5-3-13(4-6-14)19-36-38(11-17-33-12-39(35-17)20-15(25)2-1-9-32-20)21(41)37(19)10-16(23(29,30)31)34-18(40)7-8-22(26,27)28/h1-6,9,12,16H,7-8,10-11H2,(H,34,40) PECYYLGJQLWWIB-UHFFFAOYSA-N 521138 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-4,4,4-trifluorobutanamide (Racemate)::US11149023, Example 32 Vasopressin V2 receptor Human 78.2 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521138&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564231 461598557 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100792 FC(F)(F)CCC(=O)N[C@H](Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H18Cl2F6N8O2/c24-14-5-3-13(4-6-14)19-36-38(11-17-33-12-39(35-17)20-15(25)2-1-9-32-20)21(41)37(19)10-16(23(29,30)31)34-18(40)7-8-22(26,27)28/h1-6,9,12,16H,7-8,10-11H2,(H,34,40)/t16-/m1/s1 PECYYLGJQLWWIB-MRXNPFEDSA-N 521139 US11149023, Example 33 Vasopressin V1a receptor Human 215 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521139&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678027 461598558 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100793 FC(F)(F)CCC(=O)N[C@H](Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H18Cl2F6N8O2/c24-14-5-3-13(4-6-14)19-36-38(11-17-33-12-39(35-17)20-15(25)2-1-9-32-20)21(41)37(19)10-16(23(29,30)31)34-18(40)7-8-22(26,27)28/h1-6,9,12,16H,7-8,10-11H2,(H,34,40)/t16-/m1/s1 PECYYLGJQLWWIB-MRXNPFEDSA-N 521139 US11149023, Example 33 Vasopressin V2 receptor Human 5600 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521139&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678027 461598558 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100794 FC(F)(F)CCC(=O)N[C@@H](Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H18Cl2F6N8O2/c24-14-5-3-13(4-6-14)19-36-38(11-17-33-12-39(35-17)20-15(25)2-1-9-32-20)21(41)37(19)10-16(23(29,30)31)34-18(40)7-8-22(26,27)28/h1-6,9,12,16H,7-8,10-11H2,(H,34,40)/t16-/m0/s1 PECYYLGJQLWWIB-INIZCTEOSA-N 521140 US11149023, Example 34 Vasopressin V1a receptor Human 0.820 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521140&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678028 461598559 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100795 FC(F)(F)CCC(=O)N[C@@H](Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H18Cl2F6N8O2/c24-14-5-3-13(4-6-14)19-36-38(11-17-33-12-39(35-17)20-15(25)2-1-9-32-20)21(41)37(19)10-16(23(29,30)31)34-18(40)7-8-22(26,27)28/h1-6,9,12,16H,7-8,10-11H2,(H,34,40)/t16-/m0/s1 PECYYLGJQLWWIB-INIZCTEOSA-N 521140 US11149023, Example 34 Vasopressin V2 receptor Human 33.5 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521140&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678028 461598559 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100796 FC(F)(F)[C@H](CN(C(=O)NCc1ncn(n1)-c1ncccc1Cl)C(=N)c1ccc(Cl)cc1)NC(=O)[C@@H]1CCC(=O)N1 InChI=1S/C24H22Cl2F3N9O3/c25-14-5-3-13(4-6-14)20(30)37(11-17(24(27,28)29)35-22(40)16-7-8-19(39)34-16)23(41)32-10-18-33-12-38(36-18)21-15(26)2-1-9-31-21/h1-6,9,12,16-17,30H,7-8,10-11H2,(H,32,41)(H,34,39)(H,35,40)/t16-,17-/m0/s1 FLKNEUDCRDQUMS-IRXDYDNUSA-N 521141 US11149023, Example 36 Vasopressin V1a receptor Human 3.50 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521141 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521141&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678029 461598560 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100797 FC(F)(F)[C@H](CN(C(=O)NCc1ncn(n1)-c1ncccc1Cl)C(=N)c1ccc(Cl)cc1)NC(=O)[C@@H]1CCC(=O)N1 InChI=1S/C24H22Cl2F3N9O3/c25-14-5-3-13(4-6-14)20(30)37(11-17(24(27,28)29)35-22(40)16-7-8-19(39)34-16)23(41)32-10-18-33-12-38(36-18)21-15(26)2-1-9-31-21/h1-6,9,12,16-17,30H,7-8,10-11H2,(H,32,41)(H,34,39)(H,35,40)/t16-,17-/m0/s1 FLKNEUDCRDQUMS-IRXDYDNUSA-N 521141 US11149023, Example 36 Vasopressin V2 receptor Human 890 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521141 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521141&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678029 461598560 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100798 FC(F)(F)[C@@H](CN(C(=O)NCc1ncn(n1)-c1ncccc1Cl)C(=N)c1ccc(Cl)cc1)NC(=O)[C@@H]1CCC(=O)N1 InChI=1S/C24H22Cl2F3N9O3/c25-14-5-3-13(4-6-14)20(30)37(11-17(24(27,28)29)35-22(40)16-7-8-19(39)34-16)23(41)32-10-18-33-12-38(36-18)21-15(26)2-1-9-31-21/h1-6,9,12,16-17,30H,7-8,10-11H2,(H,32,41)(H,34,39)(H,35,40)/t16-,17+/m0/s1 FLKNEUDCRDQUMS-DLBZAZTESA-N 521142 US11149023, Example 37 Vasopressin V1a receptor Human 295 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521142 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521142&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678030 461598561 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100799 FC(F)(F)[C@@H](CN(C(=O)NCc1ncn(n1)-c1ncccc1Cl)C(=N)c1ccc(Cl)cc1)NC(=O)[C@@H]1CCC(=O)N1 InChI=1S/C24H22Cl2F3N9O3/c25-14-5-3-13(4-6-14)20(30)37(11-17(24(27,28)29)35-22(40)16-7-8-19(39)34-16)23(41)32-10-18-33-12-38(36-18)21-15(26)2-1-9-31-21/h1-6,9,12,16-17,30H,7-8,10-11H2,(H,32,41)(H,34,39)(H,35,40)/t16-,17+/m0/s1 FLKNEUDCRDQUMS-DLBZAZTESA-N 521142 US11149023, Example 37 Vasopressin V2 receptor Human 32000 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521142 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521142&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678030 461598561 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100800 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CS(=O)(=O)C1 InChI=1S/C23H19Cl2F3N8O4S/c24-15-5-3-13(4-6-15)19-33-35(9-18-30-12-36(32-18)20-16(25)2-1-7-29-20)22(38)34(19)8-17(23(26,27)28)31-21(37)14-10-41(39,40)11-14/h1-7,12,14,17H,8-11H2,(H,31,37) KHQMNMAJGZDPLL-UHFFFAOYSA-N 521143 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}thietane-3-carboxamide 1,1-dioxide (Racemate)::US11149023, Example 38 Vasopressin V1a receptor Human 1.70 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521143&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564223 461598562 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100801 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CS(=O)(=O)C1 InChI=1S/C23H19Cl2F3N8O4S/c24-15-5-3-13(4-6-15)19-33-35(9-18-30-12-36(32-18)20-16(25)2-1-7-29-20)22(38)34(19)8-17(23(26,27)28)31-21(37)14-10-41(39,40)11-14/h1-7,12,14,17H,8-11H2,(H,31,37) KHQMNMAJGZDPLL-UHFFFAOYSA-N 521143 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}thietane-3-carboxamide 1,1-dioxide (Racemate)::US11149023, Example 38 Vasopressin V2 receptor Human 48.0 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521143&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564223 461598562 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100802 FC(F)(F)[C@@H](Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CS(=O)(=O)C1 InChI=1S/C23H19Cl2F3N8O4S/c24-15-5-3-13(4-6-15)19-33-35(9-18-30-12-36(32-18)20-16(25)2-1-7-29-20)22(38)34(19)8-17(23(26,27)28)31-21(37)14-10-41(39,40)11-14/h1-7,12,14,17H,8-11H2,(H,31,37)/t17-/m1/s1 KHQMNMAJGZDPLL-QGZVFWFLSA-N 521144 US11149023, Example 39 Vasopressin V1a receptor Human 0.480 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521144&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678031 461598563 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100803 FC(F)(F)[C@@H](Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CS(=O)(=O)C1 InChI=1S/C23H19Cl2F3N8O4S/c24-15-5-3-13(4-6-15)19-33-35(9-18-30-12-36(32-18)20-16(25)2-1-7-29-20)22(38)34(19)8-17(23(26,27)28)31-21(37)14-10-41(39,40)11-14/h1-7,12,14,17H,8-11H2,(H,31,37)/t17-/m1/s1 KHQMNMAJGZDPLL-QGZVFWFLSA-N 521144 US11149023, Example 39 Vasopressin V2 receptor Human 53.2 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521144&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678031 461598563 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100804 FC(F)(F)[C@H](Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CS(=O)(=O)C1 InChI=1S/C23H19Cl2F3N8O4S/c24-15-5-3-13(4-6-15)19-33-35(9-18-30-12-36(32-18)20-16(25)2-1-7-29-20)22(38)34(19)8-17(23(26,27)28)31-21(37)14-10-41(39,40)11-14/h1-7,12,14,17H,8-11H2,(H,31,37)/t17-/m0/s1 KHQMNMAJGZDPLL-KRWDZBQOSA-N 521145 US11149023, Example 40 Vasopressin V1a receptor Human 370 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521145&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678032 461598564 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100805 FC(F)(F)[C@H](Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CS(=O)(=O)C1 InChI=1S/C23H19Cl2F3N8O4S/c24-15-5-3-13(4-6-15)19-33-35(9-18-30-12-36(32-18)20-16(25)2-1-7-29-20)22(38)34(19)8-17(23(26,27)28)31-21(37)14-10-41(39,40)11-14/h1-7,12,14,17H,8-11H2,(H,31,37)/t17-/m0/s1 KHQMNMAJGZDPLL-KRWDZBQOSA-N 521145 US11149023, Example 40 Vasopressin V2 receptor Human 9875 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521145&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678032 461598564 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100806 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1(CC1)C(F)(F)F InChI=1S/C24H18Cl2F6N8O2/c25-14-5-3-13(4-6-14)18-37-39(11-17-34-12-40(36-17)19-15(26)2-1-9-33-19)21(42)38(18)10-16(23(27,28)29)35-20(41)22(7-8-22)24(30,31)32/h1-6,9,12,16H,7-8,10-11H2,(H,35,41) IMYGSCWUXRQNTN-UHFFFAOYSA-N 521146 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-1-(trifluoromethyl)cyclopropane-carboxamide (Racemate)::US11149023, Example 41 Vasopressin V1a receptor Human 1.50 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521146 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521146&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621896 461598565 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100807 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1(CC1)C(F)(F)F InChI=1S/C24H18Cl2F6N8O2/c25-14-5-3-13(4-6-14)18-37-39(11-17-34-12-40(36-17)19-15(26)2-1-9-33-19)21(42)38(18)10-16(23(27,28)29)35-20(41)22(7-8-22)24(30,31)32/h1-6,9,12,16H,7-8,10-11H2,(H,35,41) IMYGSCWUXRQNTN-UHFFFAOYSA-N 521146 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-1-(trifluoromethyl)cyclopropane-carboxamide (Racemate)::US11149023, Example 41 Vasopressin V2 receptor Human 57.0 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521146 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521146&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621896 461598565 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100808 FC(F)(F)[C@@H](Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1(CC1)C(F)(F)F InChI=1S/C24H18Cl2F6N8O2/c25-14-5-3-13(4-6-14)18-37-39(11-17-34-12-40(36-17)19-15(26)2-1-9-33-19)21(42)38(18)10-16(23(27,28)29)35-20(41)22(7-8-22)24(30,31)32/h1-6,9,12,16H,7-8,10-11H2,(H,35,41)/t16-/m1/s1 IMYGSCWUXRQNTN-MRXNPFEDSA-N 521147 US11149023, Example 42 Vasopressin V1a receptor Human 1350 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521147&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678033 461598566 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100809 FC(F)(F)[C@@H](Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1(CC1)C(F)(F)F InChI=1S/C24H18Cl2F6N8O2/c25-14-5-3-13(4-6-14)18-37-39(11-17-34-12-40(36-17)19-15(26)2-1-9-33-19)21(42)38(18)10-16(23(27,28)29)35-20(41)22(7-8-22)24(30,31)32/h1-6,9,12,16H,7-8,10-11H2,(H,35,41)/t16-/m1/s1 IMYGSCWUXRQNTN-MRXNPFEDSA-N 521147 US11149023, Example 42 Vasopressin V2 receptor Human 12150 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521147&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678033 461598566 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100810 FC(F)(F)[C@H](Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1(CC1)C(F)(F)F InChI=1S/C24H18Cl2F6N8O2/c25-14-5-3-13(4-6-14)18-37-39(11-17-34-12-40(36-17)19-15(26)2-1-9-33-19)21(42)38(18)10-16(23(27,28)29)35-20(41)22(7-8-22)24(30,31)32/h1-6,9,12,16H,7-8,10-11H2,(H,35,41)/t16-/m0/s1 IMYGSCWUXRQNTN-INIZCTEOSA-N 521148 US11149023, Example 43 Vasopressin V1a receptor Human 1.40 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521148&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678034 461598567 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100811 FC(F)(F)[C@H](Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1(CC1)C(F)(F)F InChI=1S/C24H18Cl2F6N8O2/c25-14-5-3-13(4-6-14)18-37-39(11-17-34-12-40(36-17)19-15(26)2-1-9-33-19)21(42)38(18)10-16(23(27,28)29)35-20(41)22(7-8-22)24(30,31)32/h1-6,9,12,16H,7-8,10-11H2,(H,35,41)/t16-/m0/s1 IMYGSCWUXRQNTN-INIZCTEOSA-N 521148 US11149023, Example 43 Vasopressin V2 receptor Human 57.2 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521148&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678034 461598567 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100812 CS(=O)(=O)CC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H19Cl2F3N8O4S/c1-40(38,39)11-18(36)30-16(22(25,26)27)9-33-19(13-4-6-14(23)7-5-13)32-34(21(33)37)10-17-29-12-35(31-17)20-15(24)3-2-8-28-20/h2-8,12,16H,9-11H2,1H3,(H,30,36) VFXPCVBUMMROTO-UHFFFAOYSA-N 521149 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-(methylsulfonyl)acetamide (Racemate)::US11149023, Example 44 Vasopressin V1a receptor Human 1.75 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521149&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621885 461598568 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100813 CS(=O)(=O)CC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H19Cl2F3N8O4S/c1-40(38,39)11-18(36)30-16(22(25,26)27)9-33-19(13-4-6-14(23)7-5-13)32-34(21(33)37)10-17-29-12-35(31-17)20-15(24)3-2-8-28-20/h2-8,12,16H,9-11H2,1H3,(H,30,36) VFXPCVBUMMROTO-UHFFFAOYSA-N 521149 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-(methylsulfonyl)acetamide (Racemate)::US11149023, Example 44 Vasopressin V2 receptor Human 120 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521149&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621885 461598568 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100814 CS(=O)(=O)CC(=O)N[C@H](Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H19Cl2F3N8O4S/c1-40(38,39)11-18(36)30-16(22(25,26)27)9-33-19(13-4-6-14(23)7-5-13)32-34(21(33)37)10-17-29-12-35(31-17)20-15(24)3-2-8-28-20/h2-8,12,16H,9-11H2,1H3,(H,30,36)/t16-/m1/s1 VFXPCVBUMMROTO-MRXNPFEDSA-N 521150 US11149023, Example 45 Vasopressin V1a receptor Human 235 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521150&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678035 461598569 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100815 CS(=O)(=O)CC(=O)N[C@H](Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H19Cl2F3N8O4S/c1-40(38,39)11-18(36)30-16(22(25,26)27)9-33-19(13-4-6-14(23)7-5-13)32-34(21(33)37)10-17-29-12-35(31-17)20-15(24)3-2-8-28-20/h2-8,12,16H,9-11H2,1H3,(H,30,36)/t16-/m1/s1 VFXPCVBUMMROTO-MRXNPFEDSA-N 521150 US11149023, Example 45 Vasopressin V2 receptor Human 2300 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521150&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678035 461598569 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100816 CS(=O)(=O)CC(=O)N[C@@H](Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H19Cl2F3N8O4S/c1-40(38,39)11-18(36)30-16(22(25,26)27)9-33-19(13-4-6-14(23)7-5-13)32-34(21(33)37)10-17-29-12-35(31-17)20-15(24)3-2-8-28-20/h2-8,12,16H,9-11H2,1H3,(H,30,36)/t16-/m0/s1 VFXPCVBUMMROTO-INIZCTEOSA-N 521151 US11149023, Example 46 Vasopressin V1a receptor Human 1.35 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521151 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521151&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678036 461598570 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100817 CS(=O)(=O)CC(=O)N[C@@H](Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H19Cl2F3N8O4S/c1-40(38,39)11-18(36)30-16(22(25,26)27)9-33-19(13-4-6-14(23)7-5-13)32-34(21(33)37)10-17-29-12-35(31-17)20-15(24)3-2-8-28-20/h2-8,12,16H,9-11H2,1H3,(H,30,36)/t16-/m0/s1 VFXPCVBUMMROTO-INIZCTEOSA-N 521151 US11149023, Example 46 Vasopressin V2 receptor Human 57.8 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521151 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521151&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 162678036 461598570 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100818 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CCCN1 InChI=1S/C24H22Cl2F3N9O2/c25-15-7-5-14(6-8-15)20-35-37(12-19-32-13-38(34-19)21-16(26)3-1-10-31-21)23(40)36(20)11-18(24(27,28)29)33-22(39)17-4-2-9-30-17/h1,3,5-8,10,13,17-18,30H,2,4,9,11-12H2,(H,33,39) LLTRIAGHNROFKP-UHFFFAOYSA-N 521152 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-prolinamide (Diastereomeric Mixture)::US11149023, Example 47 Vasopressin V1a receptor Human 1.85 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521152&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564232 461598571 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100819 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CCCN1 InChI=1S/C24H22Cl2F3N9O2/c25-15-7-5-14(6-8-15)20-35-37(12-19-32-13-38(34-19)21-16(26)3-1-10-31-21)23(40)36(20)11-18(24(27,28)29)33-22(39)17-4-2-9-30-17/h1,3,5-8,10,13,17-18,30H,2,4,9,11-12H2,(H,33,39) LLTRIAGHNROFKP-UHFFFAOYSA-N 521152 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-prolinamide (Diastereomeric Mixture)::US11149023, Example 47 Vasopressin V2 receptor Human 50.0 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521152&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564232 461598571 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100820 F[C@H]1CNC(C1)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C24H21Cl2F4N9O2/c25-14-5-3-13(4-6-14)20-36-38(11-19-33-12-39(35-19)21-16(26)2-1-7-31-21)23(41)37(20)10-18(24(28,29)30)34-22(40)17-8-15(27)9-32-17/h1-7,12,15,17-18,32H,8-11H2,(H,34,40)/t15-,17?,18?/m1/s1 AHZBXISCIKZVCM-FAEJEUNOSA-N 521153 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-4-fluoro-prolinamide (Diastereomeric Mixture Cis Configured)::US11149023, Example 48 Vasopressin V1a receptor Human 5.40 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521153 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521153&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621914 461598572 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100821 F[C@H]1CNC(C1)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C24H21Cl2F4N9O2/c25-14-5-3-13(4-6-14)20-36-38(11-19-33-12-39(35-19)21-16(26)2-1-7-31-21)23(41)37(20)10-18(24(28,29)30)34-22(40)17-8-15(27)9-32-17/h1-7,12,15,17-18,32H,8-11H2,(H,34,40)/t15-,17?,18?/m1/s1 AHZBXISCIKZVCM-FAEJEUNOSA-N 521153 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-4-fluoro-prolinamide (Diastereomeric Mixture Cis Configured)::US11149023, Example 48 Vasopressin V2 receptor Human 305 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521153 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521153&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621914 461598572 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100822 F[C@@H]1CNC(C1)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C24H21Cl2F4N9O2/c25-14-5-3-13(4-6-14)20-36-38(11-19-33-12-39(35-19)21-16(26)2-1-7-31-21)23(41)37(20)10-18(24(28,29)30)34-22(40)17-8-15(27)9-32-17/h1-7,12,15,17-18,32H,8-11H2,(H,34,40)/t15-,17?,18?/m0/s1 AHZBXISCIKZVCM-ZLPCBKJTSA-N 521154 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-4-fluoro-prolinamide (Diastereomeric Mixture Trans Configured)::US11149023, Example 49 Vasopressin V1a receptor Human 3.35 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521154&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621906 461598573 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100823 F[C@@H]1CNC(C1)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C24H21Cl2F4N9O2/c25-14-5-3-13(4-6-14)20-36-38(11-19-33-12-39(35-19)21-16(26)2-1-7-31-21)23(41)37(20)10-18(24(28,29)30)34-22(40)17-8-15(27)9-32-17/h1-7,12,15,17-18,32H,8-11H2,(H,34,40)/t15-,17?,18?/m0/s1 AHZBXISCIKZVCM-ZLPCBKJTSA-N 521154 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-4-fluoro-prolinamide (Diastereomeric Mixture Trans Configured)::US11149023, Example 49 Vasopressin V2 receptor Human 378 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521154&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621906 461598573 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100824 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)[C@H]1CC(CN1)C(F)(F)F InChI=1S/C25H21Cl2F6N9O2/c26-15-5-3-13(4-6-15)20-39-41(11-19-36-12-42(38-19)21-16(27)2-1-7-34-21)23(44)40(20)10-18(25(31,32)33)37-22(43)17-8-14(9-35-17)24(28,29)30/h1-7,12,14,17-18,35H,8-11H2,(H,37,43)/t14?,17-,18?/m1/s1 QZHOFLRJRNXJMB-ZCDVPAHGSA-N 521155 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-trifluoropropan-2-yl}-1,1,1-trifluoropropan-2-yl}-4-(trifluoromethyl)-prolinamide (Diastereomeric Mixture Cis Configured)::US11149023, Example 50 Vasopressin V1a receptor Human 3.20 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521155&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564241 461598574 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100825 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)[C@H]1CC(CN1)C(F)(F)F InChI=1S/C25H21Cl2F6N9O2/c26-15-5-3-13(4-6-15)20-39-41(11-19-36-12-42(38-19)21-16(27)2-1-7-34-21)23(44)40(20)10-18(25(31,32)33)37-22(43)17-8-14(9-35-17)24(28,29)30/h1-7,12,14,17-18,35H,8-11H2,(H,37,43)/t14?,17-,18?/m1/s1 QZHOFLRJRNXJMB-ZCDVPAHGSA-N 521155 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-trifluoropropan-2-yl}-1,1,1-trifluoropropan-2-yl}-4-(trifluoromethyl)-prolinamide (Diastereomeric Mixture Cis Configured)::US11149023, Example 50 Vasopressin V2 receptor Human 150 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521155&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564241 461598574 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100826 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CCNC1=O InChI=1S/C24H20Cl2F3N9O3/c25-14-5-3-13(4-6-14)19-35-37(11-18-32-12-38(34-18)20-16(26)2-1-8-30-20)23(41)36(19)10-17(24(27,28)29)33-22(40)15-7-9-31-21(15)39/h1-6,8,12,15,17H,7,9-11H2,(H,31,39)(H,33,40) UYACBUOCUXQEQZ-UHFFFAOYSA-N 521156 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-oxopyrrolidine-3-carboxamide (Diastereomeric Mixture)::US11149023, Example 51 Vasopressin V1a receptor Human 2.90 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521156&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564263 461598575 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100827 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CCNC1=O InChI=1S/C24H20Cl2F3N9O3/c25-14-5-3-13(4-6-14)19-35-37(11-18-32-12-38(34-18)20-16(26)2-1-8-30-20)23(41)36(19)10-17(24(27,28)29)33-22(40)15-7-9-31-21(15)39/h1-6,8,12,15,17H,7,9-11H2,(H,31,39)(H,33,40) UYACBUOCUXQEQZ-UHFFFAOYSA-N 521156 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-oxopyrrolidine-3-carboxamide (Diastereomeric Mixture)::US11149023, Example 51 Vasopressin V2 receptor Human 167 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521156&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564263 461598575 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100828 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)c1ccc(Cl)s1 InChI=1S/C24H16Cl3F3N8O2S/c25-14-5-3-13(4-6-14)20-35-37(11-19-32-12-38(34-19)21-15(26)2-1-9-31-21)23(40)36(20)10-17(24(28,29)30)33-22(39)16-7-8-18(27)41-16/h1-9,12,17H,10-11H2,(H,33,39) UWTHWMLQZNPELF-UHFFFAOYSA-N 521157 5-Chloro-N-{3-[3-(4-chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}thiophene-2-carboxamide (Racemate)::US11149023, Example 52 Vasopressin V1a receptor Human 2.80 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521157&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564250 461598576 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100829 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)c1ccc(Cl)s1 InChI=1S/C24H16Cl3F3N8O2S/c25-14-5-3-13(4-6-14)20-35-37(11-19-32-12-38(34-19)21-15(26)2-1-9-31-21)23(40)36(20)10-17(24(28,29)30)33-22(39)16-7-8-18(27)41-16/h1-9,12,17H,10-11H2,(H,33,39) UWTHWMLQZNPELF-UHFFFAOYSA-N 521157 5-Chloro-N-{3-[3-(4-chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}thiophene-2-carboxamide (Racemate)::US11149023, Example 52 Vasopressin V2 receptor Human 470 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521157&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564250 461598576 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100830 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CC(F)(F)CN1 InChI=1S/C24H20Cl2F5N9O2/c25-14-5-3-13(4-6-14)19-37-39(10-18-34-12-40(36-18)20-15(26)2-1-7-32-20)22(42)38(19)9-17(24(29,30)31)35-21(41)16-8-23(27,28)11-33-16/h1-7,12,16-17,33H,8-11H2,(H,35,41) KOVUSQJAPVOSKT-UHFFFAOYSA-N 521158 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-4,4-difluoro-prolinamide (Diastereomeric Mixture)::US11149023, Example 53 Vasopressin V1a receptor Human 1.60 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521158&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564235 461598577 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100831 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CC(F)(F)CN1 InChI=1S/C24H20Cl2F5N9O2/c25-14-5-3-13(4-6-14)19-37-39(10-18-34-12-40(36-18)20-15(26)2-1-7-32-20)22(42)38(19)9-17(24(29,30)31)35-21(41)16-8-23(27,28)11-33-16/h1-7,12,16-17,33H,8-11H2,(H,35,41) KOVUSQJAPVOSKT-UHFFFAOYSA-N 521158 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-4,4-difluoro-prolinamide (Diastereomeric Mixture)::US11149023, Example 53 Vasopressin V2 receptor Human 38.0 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521158&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564235 461598577 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100832 CC(C)(C)OC(=O)N1CC(F)(F)C1C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C28H26Cl2F5N9O4/c1-26(2,3)48-25(47)42-13-27(31,32)20(42)23(45)38-18(28(33,34)35)11-41-21(15-6-8-16(29)9-7-15)40-43(24(41)46)12-19-37-14-44(39-19)22-17(30)5-4-10-36-22/h4-10,14,18,20H,11-13H2,1-3H3,(H,38,45) IYDLWKJZWBLCQJ-UHFFFAOYSA-N 521159 US11149023, Example 54::tert-Butyl 2-({3-[3-(4-chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}carbamoyl)-3,3-difluoro-azetidine-1-carboxylate (Diastereomeric Mixture) Vasopressin V1a receptor Human 3.90 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521159&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564258 461598578 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100833 CC(C)(C)OC(=O)N1CC(F)(F)C1C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C28H26Cl2F5N9O4/c1-26(2,3)48-25(47)42-13-27(31,32)20(42)23(45)38-18(28(33,34)35)11-41-21(15-6-8-16(29)9-7-15)40-43(24(41)46)12-19-37-14-44(39-19)22-17(30)5-4-10-36-22/h4-10,14,18,20H,11-13H2,1-3H3,(H,38,45) IYDLWKJZWBLCQJ-UHFFFAOYSA-N 521159 US11149023, Example 54::tert-Butyl 2-({3-[3-(4-chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}carbamoyl)-3,3-difluoro-azetidine-1-carboxylate (Diastereomeric Mixture) Vasopressin V2 receptor Human 165 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521159&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564258 461598578 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100834 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1NCC1(F)F InChI=1S/C23H18Cl2F5N9O2/c24-13-5-3-12(4-6-13)18-36-38(9-16-33-11-39(35-16)19-14(25)2-1-7-31-19)21(41)37(18)8-15(23(28,29)30)34-20(40)17-22(26,27)10-32-17/h1-7,11,15,17,32H,8-10H2,(H,34,40) RUCNKOMMAZUMRZ-UHFFFAOYSA-N 521160 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-3,3-difluoroazetidine-2-carboxamide (Diastereomeric Mixture)::US11149023, Example 55 Vasopressin V1a receptor Human 1.95 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521160&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564247 461598579 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100835 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1NCC1(F)F InChI=1S/C23H18Cl2F5N9O2/c24-13-5-3-12(4-6-13)18-36-38(9-16-33-11-39(35-16)19-14(25)2-1-7-31-19)21(41)37(18)8-15(23(28,29)30)34-20(40)17-22(26,27)10-32-17/h1-7,11,15,17,32H,8-10H2,(H,34,40) RUCNKOMMAZUMRZ-UHFFFAOYSA-N 521160 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-3,3-difluoroazetidine-2-carboxamide (Diastereomeric Mixture)::US11149023, Example 55 Vasopressin V2 receptor Human 106 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521160&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564247 461598579 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100836 CC(C)(C)OC(=O)N1CCC1C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C28H28Cl2F3N9O4/c1-27(2,3)46-26(45)39-12-10-19(39)24(43)36-20(28(31,32)33)13-40-22(16-6-8-17(29)9-7-16)38-41(25(40)44)14-21-35-15-42(37-21)23-18(30)5-4-11-34-23/h4-9,11,15,19-20H,10,12-14H2,1-3H3,(H,36,43) OZXVXSMFLZWPEG-UHFFFAOYSA-N 521161 US11149023, Example 56::tert-Butyl 2-({3-[3-(4-chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}carbamoyl)azetidine-1-carboxylate (Diastereomeric Mixture) Vasopressin V1a receptor Human 8.10 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521161&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621903 461598580 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100837 CC(C)(C)OC(=O)N1CCC1C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C28H28Cl2F3N9O4/c1-27(2,3)46-26(45)39-12-10-19(39)24(43)36-20(28(31,32)33)13-40-22(16-6-8-17(29)9-7-16)38-41(25(40)44)14-21-35-15-42(37-21)23-18(30)5-4-11-34-23/h4-9,11,15,19-20H,10,12-14H2,1-3H3,(H,36,43) OZXVXSMFLZWPEG-UHFFFAOYSA-N 521161 US11149023, Example 56::tert-Butyl 2-({3-[3-(4-chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}carbamoyl)azetidine-1-carboxylate (Diastereomeric Mixture) Vasopressin V2 receptor Human 1027 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521161&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621903 461598580 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100838 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CCN1 InChI=1S/C23H20Cl2F3N9O2/c24-14-5-3-13(4-6-14)19-34-36(11-18-31-12-37(33-18)20-15(25)2-1-8-30-20)22(39)35(19)10-17(23(26,27)28)32-21(38)16-7-9-29-16/h1-6,8,12,16-17,29H,7,9-11H2,(H,32,38) MMLXWHAIOOQQTQ-UHFFFAOYSA-N 521162 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}azetidine-2-carboxamide (Diastereomeric Mixture)::US11149023, Example 57 Vasopressin V1a receptor Human 31.5 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521162&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564218 461598581 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100839 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CCN1 InChI=1S/C23H20Cl2F3N9O2/c24-14-5-3-13(4-6-14)19-34-36(11-18-31-12-37(33-18)20-15(25)2-1-8-30-20)22(39)35(19)10-17(23(26,27)28)32-21(38)16-7-9-29-16/h1-6,8,12,16-17,29H,7,9-11H2,(H,32,38) MMLXWHAIOOQQTQ-UHFFFAOYSA-N 521162 N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}azetidine-2-carboxamide (Diastereomeric Mixture)::US11149023, Example 57 Vasopressin V2 receptor Human 1977 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521162&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564218 461598581 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100840 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)NC(=O)C1(CC1)C(F)(F)F InChI=1S/C25H18ClF9N8O2/c26-14-5-3-13(4-6-14)18-40-42(11-17-37-12-43(39-17)19-15(23(27,28)29)2-1-9-36-19)21(45)41(18)10-16(24(30,31)32)38-20(44)22(7-8-22)25(33,34)35/h1-6,9,12,16H,7-8,10-11H2,(H,38,44) FYOZKCPPNGGSSM-UHFFFAOYSA-N 521163 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-1-(trifluoromethyl)cyclopropane-1-carboxamide (Racemate)::US11149023, Example 58 Vasopressin V1a receptor Human 3.00 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521163&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621911 461598582 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100841 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)NC(=O)C1(CC1)C(F)(F)F InChI=1S/C25H18ClF9N8O2/c26-14-5-3-13(4-6-14)18-40-42(11-17-37-12-43(39-17)19-15(23(27,28)29)2-1-9-36-19)21(45)41(18)10-16(24(30,31)32)38-20(44)22(7-8-22)25(33,34)35/h1-6,9,12,16H,7-8,10-11H2,(H,38,44) FYOZKCPPNGGSSM-UHFFFAOYSA-N 521163 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-1-(trifluoromethyl)cyclopropane-1-carboxamide (Racemate)::US11149023, Example 58 Vasopressin V2 receptor Human 120 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521163&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621911 461598582 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100842 FC(F)(F)CCC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C24H18ClF9N8O2/c25-14-5-3-13(4-6-14)19-39-41(11-17-36-12-42(38-17)20-15(23(29,30)31)2-1-9-35-20)21(44)40(19)10-16(24(32,33)34)37-18(43)7-8-22(26,27)28/h1-6,9,12,16H,7-8,10-11H2,(H,37,43) GVTMMJDLFLCNLI-UHFFFAOYSA-N 521164 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-4,4,4-trifluorobutanamide (Racemate)::US11149023, Example 59 Vasopressin V1a receptor Human 1.90 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521164&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564219 461598583 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100843 FC(F)(F)CCC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C24H18ClF9N8O2/c25-14-5-3-13(4-6-14)19-39-41(11-17-36-12-42(38-17)20-15(23(29,30)31)2-1-9-35-20)21(44)40(19)10-16(24(32,33)34)37-18(43)7-8-22(26,27)28/h1-6,9,12,16H,7-8,10-11H2,(H,37,43) GVTMMJDLFLCNLI-UHFFFAOYSA-N 521164 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-4,4,4-trifluorobutanamide (Racemate)::US11149023, Example 59 Vasopressin V2 receptor Human 75.0 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521164&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564219 461598583 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100844 CC(F)(F)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H17ClF8N8O2/c1-21(25,26)19(41)35-15(23(30,31)32)9-38-17(12-4-6-13(24)7-5-12)37-39(20(38)42)10-16-34-11-40(36-16)18-14(22(27,28)29)3-2-8-33-18/h2-8,11,15H,9-10H2,1H3,(H,35,41) GHJFSCUPNNHBCP-UHFFFAOYSA-N 521165 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2,2-difluoropropanamide (Racemate)::US11149023, Example 60 Vasopressin V1a receptor Human 18.5 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521165&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564257 461598584 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100845 CC(F)(F)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H17ClF8N8O2/c1-21(25,26)19(41)35-15(23(30,31)32)9-38-17(12-4-6-13(24)7-5-12)37-39(20(38)42)10-16-34-11-40(36-16)18-14(22(27,28)29)3-2-8-33-18/h2-8,11,15H,9-10H2,1H3,(H,35,41) GHJFSCUPNNHBCP-UHFFFAOYSA-N 521165 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2,2-difluoropropanamide (Racemate)::US11149023, Example 60 Vasopressin V2 receptor Human 1550 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521165&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564257 461598584 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100846 FCC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H16ClF7N8O2/c23-13-5-3-12(4-6-13)18-35-37(20(40)36(18)9-15(22(28,29)30)33-17(39)8-24)10-16-32-11-38(34-16)19-14(21(25,26)27)2-1-7-31-19/h1-7,11,15H,8-10H2,(H,33,39) CQGJLNBFEYBTIR-UHFFFAOYSA-N 521166 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-fluoroacetamide (Racemate)::US11149023, Example 61 Vasopressin V1a receptor Human 50.0 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521166&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564202 461598585 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100847 FCC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C22H16ClF7N8O2/c23-13-5-3-12(4-6-13)18-35-37(20(40)36(18)9-15(22(28,29)30)33-17(39)8-24)10-16-32-11-38(34-16)19-14(21(25,26)27)2-1-7-31-19/h1-7,11,15H,8-10H2,(H,33,39) CQGJLNBFEYBTIR-UHFFFAOYSA-N 521166 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-fluoroacetamide (Racemate)::US11149023, Example 61 Vasopressin V2 receptor Human 3800 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521166&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564202 461598585 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100848 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CS(=O)(=O)C1 InChI=1S/C24H19ClF6N8O4S/c25-15-5-3-13(4-6-15)19-36-38(9-18-33-12-39(35-18)20-16(23(26,27)28)2-1-7-32-20)22(41)37(19)8-17(24(29,30)31)34-21(40)14-10-44(42,43)11-14/h1-7,12,14,17H,8-11H2,(H,34,40) YLKRSDQVBIBIIN-UHFFFAOYSA-N 521167 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-1,1-dioxo-1lambda6-thietane-3-carboxamide (Racemate)::US11149023, Example 62 Vasopressin V1a receptor Human 1.60 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521167 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521167&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621902 461598586 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100849 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CS(=O)(=O)C1 InChI=1S/C24H19ClF6N8O4S/c25-15-5-3-13(4-6-15)19-36-38(9-18-33-12-39(35-18)20-16(23(26,27)28)2-1-7-32-20)22(41)37(19)8-17(24(29,30)31)34-21(40)14-10-44(42,43)11-14/h1-7,12,14,17H,8-11H2,(H,34,40) YLKRSDQVBIBIIN-UHFFFAOYSA-N 521167 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-1,1-dioxo-1lambda6-thietane-3-carboxamide (Racemate)::US11149023, Example 62 Vasopressin V2 receptor Human 165 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521167 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521167&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621902 461598586 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100850 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CC(F)(F)C1 InChI=1S/C25H19ClF8N8O2/c26-15-5-3-13(4-6-15)19-39-41(11-18-36-12-42(38-18)20-16(24(29,30)31)2-1-7-35-20)22(44)40(19)10-17(25(32,33)34)37-21(43)14-8-23(27,28)9-14/h1-7,12,14,17H,8-11H2,(H,37,43) CSGBQCRJBAYXNV-UHFFFAOYSA-N 521168 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-3,3-difluorocyclobutane-1-carboxamide (Racemate)::US11149023, Example 63 Vasopressin V1a receptor Human 0.720 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521168&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621891 461598587 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100851 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CC(F)(F)C1 InChI=1S/C25H19ClF8N8O2/c26-15-5-3-13(4-6-15)19-39-41(11-18-36-12-42(38-18)20-16(24(29,30)31)2-1-7-35-20)22(44)40(19)10-17(25(32,33)34)37-21(43)14-8-23(27,28)9-14/h1-7,12,14,17H,8-11H2,(H,37,43) CSGBQCRJBAYXNV-UHFFFAOYSA-N 521168 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-3,3-difluorocyclobutane-1-carboxamide (Racemate)::US11149023, Example 63 Vasopressin V2 receptor Human 58.8 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521168&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621891 461598587 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100852 CS(=O)(=O)CC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H19ClF6N8O4S/c1-43(41,42)11-18(39)33-16(23(28,29)30)9-36-19(13-4-6-14(24)7-5-13)35-37(21(36)40)10-17-32-12-38(34-17)20-15(22(25,26)27)3-2-8-31-20/h2-8,12,16H,9-11H2,1H3,(H,33,39) PICUPEIXWHWVFR-UHFFFAOYSA-N 521169 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-(methanesulfonyl)acetamide (Racemate)::US11149023, Example 64 Vasopressin V1a receptor Human 1.20 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521169&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621915 461598588 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100853 CS(=O)(=O)CC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H19ClF6N8O4S/c1-43(41,42)11-18(39)33-16(23(28,29)30)9-36-19(13-4-6-14(24)7-5-13)35-37(21(36)40)10-17-32-12-38(34-17)20-15(22(25,26)27)3-2-8-31-20/h2-8,12,16H,9-11H2,1H3,(H,33,39) PICUPEIXWHWVFR-UHFFFAOYSA-N 521169 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-(methanesulfonyl)acetamide (Racemate)::US11149023, Example 64 Vasopressin V2 receptor Human 78.2 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521169&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621915 461598588 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100854 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)NC(=O)C1(CC1)C#N InChI=1S/C25H18ClF6N9O2/c26-15-5-3-14(4-6-15)19-38-40(11-18-35-13-41(37-18)20-16(24(27,28)29)2-1-9-34-20)22(43)39(19)10-17(25(30,31)32)36-21(42)23(12-33)7-8-23/h1-6,9,13,17H,7-8,10-11H2,(H,36,42) JYMGVIRSBQVNDW-UHFFFAOYSA-N 521170 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-1-cyanocyclopropane-1-carboxamide (Racemate)::US11149023, Example 65 Vasopressin V1a receptor Human 9.10 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521170&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621882 461598589 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100855 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)NC(=O)C1(CC1)C#N InChI=1S/C25H18ClF6N9O2/c26-15-5-3-14(4-6-15)19-38-40(11-18-35-13-41(37-18)20-16(24(27,28)29)2-1-9-34-20)22(43)39(19)10-17(25(30,31)32)36-21(42)23(12-33)7-8-23/h1-6,9,13,17H,7-8,10-11H2,(H,36,42) JYMGVIRSBQVNDW-UHFFFAOYSA-N 521170 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-1-cyanocyclopropane-1-carboxamide (Racemate)::US11149023, Example 65 Vasopressin V2 receptor Human 490 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521170&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621882 461598589 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100856 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CC1(F)F InChI=1S/C24H17ClF8N8O2/c25-13-5-3-12(4-6-13)18-38-40(10-17-35-11-41(37-17)19-14(23(28,29)30)2-1-7-34-19)21(43)39(18)9-16(24(31,32)33)36-20(42)15-8-22(15,26)27/h1-7,11,15-16H,8-10H2,(H,36,42) VAWQZJUNSPDCQU-UHFFFAOYSA-N 521171 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2,2-difluorocyclopropane-1-carboxamide (Diastereomeric Mixture)::US11149023, Example 66 Vasopressin V1a receptor Human 5.40 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521171&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564220 461598590 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100857 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)NC(=O)C1CC1(F)F InChI=1S/C24H17ClF8N8O2/c25-13-5-3-12(4-6-13)18-38-40(10-17-35-11-41(37-17)19-14(23(28,29)30)2-1-7-34-19)21(43)39(18)9-16(24(31,32)33)36-20(42)15-8-22(15,26)27/h1-7,11,15-16H,8-10H2,(H,36,42) VAWQZJUNSPDCQU-UHFFFAOYSA-N 521171 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2,2-difluorocyclopropane-1-carboxamide (Diastereomeric Mixture)::US11149023, Example 66 Vasopressin V2 receptor Human 245 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521171&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564220 461598590 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100858 FC(F)(F)CC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H16ClF9N8O2/c24-13-5-3-12(4-6-13)18-38-40(10-16-35-11-41(37-16)19-14(22(28,29)30)2-1-7-34-19)20(43)39(18)9-15(23(31,32)33)36-17(42)8-21(25,26)27/h1-7,11,15H,8-10H2,(H,36,42) XBYRXDQUZUKNHF-UHFFFAOYSA-N 521172 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-3,3,3-trifluoropropanamide (Racemate)::US11149023, Example 67 Vasopressin V1a receptor Human 1.15 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521172&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564242 461598591 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100859 FC(F)(F)CC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H16ClF9N8O2/c24-13-5-3-12(4-6-13)18-38-40(10-16-35-11-41(37-16)19-14(22(28,29)30)2-1-7-34-19)20(43)39(18)9-15(23(31,32)33)36-17(42)8-21(25,26)27/h1-7,11,15H,8-10H2,(H,36,42) XBYRXDQUZUKNHF-UHFFFAOYSA-N 521172 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-3,3,3-trifluoropropanamide (Racemate)::US11149023, Example 67 Vasopressin V2 receptor Human 57.0 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521172&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564242 461598591 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100860 COCC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H19ClF6N8O3/c1-41-11-18(39)33-16(23(28,29)30)9-36-19(13-4-6-14(24)7-5-13)35-37(21(36)40)10-17-32-12-38(34-17)20-15(22(25,26)27)3-2-8-31-20/h2-8,12,16H,9-11H2,1H3,(H,33,39) FAGIURAOFFKPDO-UHFFFAOYSA-N 521173 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-methoxyacetamide (Racemate)::US11149023, Example 68 Vasopressin V1a receptor Human 6.15 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521173&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564251 461598592 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100861 COCC(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C23H19ClF6N8O3/c1-41-11-18(39)33-16(23(28,29)30)9-36-19(13-4-6-14(24)7-5-13)35-37(21(36)40)10-17-32-12-38(34-17)20-15(22(25,26)27)3-2-8-31-20/h2-8,12,16H,9-11H2,1H3,(H,33,39) FAGIURAOFFKPDO-UHFFFAOYSA-N 521173 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-2-methoxyacetamide (Racemate)::US11149023, Example 68 Vasopressin V2 receptor Human 530 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521173&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564251 461598592 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100862 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)NC(=O)C1NCC1(F)F InChI=1S/C24H18ClF8N9O2/c25-13-5-3-12(4-6-13)18-39-41(9-16-36-11-42(38-16)19-14(23(28,29)30)2-1-7-34-19)21(44)40(18)8-15(24(31,32)33)37-20(43)17-22(26,27)10-35-17/h1-7,11,15,17,35H,8-10H2,(H,37,43) DXLYJBKHQDHMEM-UHFFFAOYSA-N 521174 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-3,3-difluoroazetidine-2-carboxamide Hydrochloride (Diastereomeric Mixture)::US11149023, Example 69 Vasopressin V1a receptor Human 1.95 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521174&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564208 461598593 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100863 FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)NC(=O)C1NCC1(F)F InChI=1S/C24H18ClF8N9O2/c25-13-5-3-12(4-6-13)18-39-41(9-16-36-11-42(38-16)19-14(23(28,29)30)2-1-7-34-19)21(44)40(18)8-15(24(31,32)33)37-20(43)17-22(26,27)10-35-17/h1-7,11,15,17,35H,8-10H2,(H,37,43) DXLYJBKHQDHMEM-UHFFFAOYSA-N 521174 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-3,3-difluoroazetidine-2-carboxamide Hydrochloride (Diastereomeric Mixture)::US11149023, Example 69 Vasopressin V2 receptor Human 101 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521174&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564208 461598593 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100864 F[C@H]1CN[C@@H](C1)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C25H21ClF7N9O2/c26-14-5-3-13(4-6-14)20-39-41(11-19-36-12-42(38-19)21-16(24(28,29)30)2-1-7-34-21)23(44)40(20)10-18(25(31,32)33)37-22(43)17-8-15(27)9-35-17/h1-7,12,15,17-18,35H,8-11H2,(H,37,43)/t15-,17+,18?/m1/s1 LDHCZLHYAVCLIP-OEQNEYKNSA-N 521175 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-4-fluoro-L-prolinamide hydrochloride (Diastereomeric Mixture)::US11149023, Example 70 Vasopressin V1a receptor Human 6.35 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521175&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564221 461598594 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100865 F[C@H]1CN[C@@H](C1)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C25H21ClF7N9O2/c26-14-5-3-13(4-6-14)20-39-41(11-19-36-12-42(38-19)21-16(24(28,29)30)2-1-7-34-21)23(44)40(20)10-18(25(31,32)33)37-22(43)17-8-15(27)9-35-17/h1-7,12,15,17-18,35H,8-11H2,(H,37,43)/t15-,17+,18?/m1/s1 LDHCZLHYAVCLIP-OEQNEYKNSA-N 521175 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-4-fluoro-L-prolinamide hydrochloride (Diastereomeric Mixture)::US11149023, Example 70 Vasopressin V2 receptor Human 445 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521175&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 142564221 461598594 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9 1100866 F[C@@H]1CN[C@@H](C1)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C25H21ClF7N9O2/c26-14-5-3-13(4-6-14)20-39-41(11-19-36-12-42(38-19)21-16(24(28,29)30)2-1-7-34-21)23(44)40(20)10-18(25(31,32)33)37-22(43)17-8-15(27)9-35-17/h1-7,12,15,17-18,35H,8-11H2,(H,37,43)/t15-,17-,18?/m0/s1 LDHCZLHYAVCLIP-LUIZSJORSA-N 521176 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-4-fluoro-L-prolinamide hydrochloride (Diastereomeric Mixture)::US11149023, Example 71 Vasopressin V1a receptor Human 4.90 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=325&target=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521176&enzyme=Vasopressin+V1a+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621898 461598595 1 MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST 1YTV Vasopressin V1a receptor V1AR_HUMAN P37288 1100867 F[C@@H]1CN[C@@H](C1)C(=O)NC(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C25H21ClF7N9O2/c26-14-5-3-13(4-6-14)20-39-41(11-19-36-12-42(38-19)21-16(24(28,29)30)2-1-7-34-21)23(44)40(20)10-18(25(31,32)33)37-22(43)17-8-15(27)9-35-17/h1-7,12,15,17-18,35H,8-11H2,(H,37,43)/t15-,17-,18?/m0/s1 LDHCZLHYAVCLIP-LUIZSJORSA-N 521176 N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-4-fluoro-L-prolinamide hydrochloride (Diastereomeric Mixture)::US11149023, Example 71 Vasopressin V2 receptor Human 275 US Patent 10.7270/Q2SQ93JT aid1805998 US11149023 Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H 10/19/2021 3/13/2022 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=521176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=326&target=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=521176&enzyme=Vasopressin+V2+receptor&column=ki&startPg=0&Increment=50&submit=Search 154621898 461598595 1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS 7DW9,7KH0 Vasopressin V2 receptor V2R_HUMAN P30518 C5HF20 O43192 Q3MJD3 Q9UCV9